Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.
about
Leukotrienes and aspirin induced asthmaLeukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorType 2 innate lymphoid cells: at the cross-roads in allergic asthmaInsights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseThe leukotriene C(4) synthase gene and asthmaLeukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonistMolecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophilsAnti-inflammatory effects of zileuton in a subpopulation of allergic asthmaticsAntileukotriene agents in asthma: the dart that kills the elephant?Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysemaAllergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation.Regulation of expression of the 5-lipoxygenase pathway.The measurement of leukotrienes in human fluids.Antileukotrienes and laboratory models of asthma.Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.Leukotriene C4 synthase. A pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes.Measurement of leukotrienes in humans.Asthma mediators: current views.Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Antileukotrienes in clinical development for asthma.Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsivenessThe leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cellsContrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthmaCysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteersEffect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients.Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.Uteroglobin gene expression in the rabbit uterus throughout gestation and in the fetal lung. Relationship between uteroglobin and eicosanoid levels in the developing fetal lung.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.Mast cells in airway diseases and interstitial lung diseaseThe importance of leukotrienes in airway inflammation in a mouse model of asthma.T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4.The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist.
P2860
Q24563001-A5F0A9BA-0578-41F0-A1AD-94C15B1E5803Q24647514-AF11060D-F598-4C13-B40A-0BEAD6875AB5Q26766464-2D024927-6037-4466-9665-4F58748B394BQ28076134-9DAFC75A-C2AD-47C3-855E-9C053ED93A27Q28145246-357F6975-DE16-4804-880E-945DAE37FBE1Q28275552-21E626A4-0254-43F5-9901-10FC3F13826EQ28319336-EA9ED5F7-A108-4CDD-A30D-CA0D9C28C65EQ28368966-1F98E5C6-A6F0-4CA3-A486-A2C1FFE229D7Q28376754-2A1C3D2F-D96A-4FED-80DF-83B4542315BFQ28769366-BBAA9DC7-9C4D-4C03-A91F-CEA80C6760F3Q30429404-E2477D4F-538B-43C0-9D04-0F5147EF78A9Q33588011-62AC1466-10EF-4223-BACE-AF1B1B0BE7A1Q33705470-39D801BD-8C5E-4EBE-BB51-F30DE5648674Q33705493-9470F975-98E0-4A58-978A-251E0D3C9D78Q33705512-BE6A9799-1FE9-4931-82D7-ED2E78E9D044Q33805187-0D29600D-03EF-4D14-85F3-7D3FA8308A5DQ33836679-FE097508-EB4B-4812-9E11-FDDD1C369403Q33836740-C8A69B9B-D40B-43FA-9F73-5161D152A90EQ33861545-C5D12AFD-6DA5-41E4-B81C-9E6A467CBABEQ34063491-611362DB-2CF7-44C1-B219-0B67D2031608Q34131651-25317E69-BD66-4345-9F44-4FFC933450B9Q34240729-FA6C2974-817E-48F0-91F8-11D40F191F9FQ34481959-700C66B9-D2E2-4756-8E25-9CC132FA415AQ34624361-19A6470E-C607-4897-9ABC-021988EB49F7Q34743993-F3868B0B-FBF1-47FA-8E9A-E63258EB84F0Q34971386-BFB24CB1-FB0E-419C-ABB6-6645BE19880DQ35535288-F83E7DBD-5E0A-4EFE-AC48-C4D0E05AC703Q35535997-F5876EE8-9A59-41A5-A517-7D3F4A3DB965Q35563505-B9778C77-02EE-4BA7-A496-C12E6888EA4AQ35563630-9B580921-667C-4773-A294-67D5AC4E6C5CQ35573060-C053D27F-3CF5-4959-BA8B-6CB7C035E14DQ35738005-214E8078-0B10-4AAF-B594-574D659768A3Q35750665-FE2B2F9D-CAAF-4F8E-B9E3-A576AA33D10CQ35779312-21D17B39-6039-4166-A0B5-50270D64EAF0Q35874522-EDEF6FF3-096D-4060-A0D0-16AB6D90B007Q35874712-21B0506F-03F1-48E3-9785-03B61B7EC3B8Q36260500-CA934A98-4C93-4E62-8E9B-E0F7D929DD19Q36367477-1C179A1B-0788-4046-97DA-854B4D5F80BDQ36376120-0690B32C-02C5-4050-B73C-49873F69E58EQ36440015-91BAAF20-E0F8-4505-8842-EDDADAB96382
P2860
Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Elevated levels of leukotriene ...... obronchial allergen challenge.
@en
Elevated levels of leukotriene ...... obronchial allergen challenge.
@nl
type
label
Elevated levels of leukotriene ...... obronchial allergen challenge.
@en
Elevated levels of leukotriene ...... obronchial allergen challenge.
@nl
prefLabel
Elevated levels of leukotriene ...... obronchial allergen challenge.
@en
Elevated levels of leukotriene ...... obronchial allergen challenge.
@nl
P2093
P2860
P356
P1476
Elevated levels of leukotriene ...... obronchial allergen challenge.
@en
P2093
Johnston K
Voelkel NF
Westcott JY
P2860
P304
P356
10.1164/AJRCCM/142.1.112
P577
1990-07-01T00:00:00Z